Peptide products are often presented using impressive percentages, technical language, and laboratory-style graphics. However, one isolated number rarely provides a complete picture of the material being evaluated. Reliable peptide information should answer several separate questions: Is the expected peptide present? What related components were detected? How was the material measured? Does the documentation apply to the exact batch? Was a suitable reference standard used? What storage conditions support the reported results? Strong scientific information explains both the result and the method behind it. Identity and purity are different Identity testing asks whether the sample contains the expected peptide. Mass spectrometry can compare the measured molecular mass with the expected value, while tandem mass spectrometry may provide additional sequence-related evidence. Chromatography can support identification through retention behaviour, but retention time alone is generally not enough to confirm molecular identity. Purity testing asks how much of the detected sample appears as the principal component compared with other detected components. A large HPLC peak may indicate that one component dominates the chromatogram. It does not automatically prove that the peak is the correct peptide, that all impurities were separated, or that the same percentage represents peptide content by total vial weight. Identity and purity should therefore be reviewed as complementary measurements rather than interchangeable terms. One purity percentage is not the entire result An HPLC purity percentage commonly reflects the relative area of the main detected peak under a specific analytical method. That number may be influenced by: Column chemistry Mobile phase Gradient conditions Detection settings Sample solvent Injection volume Peak integration Coeluting components Published research on synthetic peptide analysis describes closely related impurities as a significant analytical challenge and recommends combining chromatographic separation with mass-spectrometry information when deeper characterization is required. A useful report should therefore include the chromatogram and relevant method details—not only the final percentage. Reference standards support reliable measurement Many analytical results depend on comparison with a well-characterized reference material. A dependable peptide reference standard may require: Identity confirmation Purity evaluation Quantitative content assignment Vial-to-vial uniformity testing Lyophilization controls Multi-laboratory evaluation Stability monitoring McCarthy and colleagues described using chromatography, mass spectrometry, NMR, content measurements, uniformity studies, and stability testing when establishing synthetic peptide reference standards. When the reference value is inaccurate or the material changes during storage, later sample measurements may also be affected. Every result depends on the reference behind it. Batch documentation matters Analytical information should be connected to the exact batch being evaluated. Useful documentation may include: Product or sequence identification Batch or lot number Analysis date HPLC chromatogram Molecular-mass result Reported purity Assigned peptide content, when available Storage information Testing-laboratory details A general report that cannot be linked to a specific batch provides less traceability than documentation identifying the material actually tested. International analytical guidance also treats identity, purity, impurities, quantity, and reference materials as separate quality considerations rather than one combined measurement. Stability information completes the picture An analytical result describes the sample at the time it was tested. It does not automatically establish how the material will behave throughout storage. Peptides may change through oxidation, deamidation, hydrolysis, aggregation, or moisture-related processes. Stability assessment may therefore involve multiple analytical methods and planned testing intervals. ICH guidance notes that purity values can be method-dependent and generally recommends evaluating stability using more than one suitable analytical approach. Storage guidance should be connected to the specific peptide, formulation, packaging, and supporting data rather than copied from an unrelated material. The Azzurri Wellness perspective Responsible peptide communication should focus on measurable information rather than dramatic claims. A more complete quality review considers: Identity → Purity → Content → Reference standard → Batch documentation → Storage No single percentage answers all six questions. At Azzurri Wellness, the guiding principle is: Science over hype means looking beyond the headline number and understanding the evidence, method, and limitations behind every result.
References McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023;40:1317–1328. DOI: 10.1007/s11095-023-03493-1. Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography–Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. Journal of the American Society for Mass Spectrometry. 2021;32:1852–1860. International Council for Harmonisation. ICH Q6B: Specifications—Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. Educational disclaimer: This article is provided for general scientific and laboratory-information purposes. Analytical conclusions should be based on suitable reference materials, documented procedures, and appropriately validated methods.